Johnson and Johnson Asks FDA For Booster Approval

Johnson and Johnson has asked the U.S. Food and Drug Administration to authorize booster shots for it’s Coronavirus vaccine. The FDA’s Vaccine and Related Biological Products Advisory Committee is scheduled to meet on October 14th and 15th to consider requests from Moderna and Johnson and Johnson to add booster doses for their vaccines. Last month, Janssen released data from three different studies that showed boosting it’s single-shot vaccine at two months or at six months increased immune protection.

Boosting the vaccine two months after the first shot increases antibody response fourfold and was 94% effective while waiting six months to boost increased antibody protection 12-fold. Pfizer received the approval from the FDA last month for booster doses for certain people who got the original two doses six months ago or longer. According to the CDC, about 15 million people in the United States have received the Johnson and Johnson Covid-19 vaccine.